Ceretrophin Clinical Study
A double-blind, placebo controlled study examining
the effects of Ceretrophin™ vs placebo on cognitive function, energy,
state-of-mind and mood.
By Dr. Con Stough, Christina Kure, Jo Tarasuik and Luke Downey
BRAIN SCIENCES INSTITUTE
SWINBURNE UNIVERSITY, AUSTRALIA
Dr. Con Stough
Examine whether Ceretrophin™ enhances performance on tests assessing
memory, attention, executive function, alertness, speed of information
processing, mood, energy levels, stress and IQ.
This study was a Phase III, double blind, placebo controlled
exploratory trial with 150 healthy human participants that examined the
neuropsychological effects of Ceretrophin™. It was expected that
treatment with Ceretrophin™ would produce improvements in cognitive
functioning, in particular memory, attention and executive processing.
It was also anticipated that Ceretrophin™ would exert additional
benefits in improving energy levels, anxiety, depression and stress.
- The Cognitive Drug Research measure (CDR)
- Inspection Time
- UWIST Mood Adjective Checklist
- Spielberger State-Trait Anxiety Inventory
- The General Health Questionnaire (GHQ)
- IQ: Raven Progressive Matrices
Click Here to download the Ceretrophin™ Technical Report
Peer Review Publications
- Human Psychopharmacology
- Archives of General Psychiatry
- Psychological Medicine
- International Journal of Neuropsychopharmacology